Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 12.61% vs 6.91% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 52.94% vs 31.23% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 7.33% vs 8.96% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is -6.32% vs -16.68% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of ERIS Lifescience With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 2.19% vs 15.42% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 12.61% vs 6.91% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 29.10% vs -49.44% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 52.94% vs 31.23% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 4.43% vs 8.28% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 7.33% vs 8.96% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -0.49% vs 2.26% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -6.32% vs -16.68% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025